Pda Tr 59 | [exclusive]

: Provides data-driven proof for regulatory inspections.

"PDA Technical Report No. 59 (Utilization of Statistical Methods for Production Monitoring) establishes a systematic framework for applying statistical process control in pharmaceutical manufacturing. It emphasizes the use of control charts, process capability indices, and rational subgrouping to detect non-random variation in real time. The report provides specific guidance on setting alert and action limits, handling environmental monitoring data in aseptic processing, and integrating statistical monitoring into a compliant quality system per ICH Q10."

The full 74-page document is available for purchase at the PDA Bookstore. pda tr 59

TR 59 works in tandem with other critical PDA documents to form a comprehensive quality system:

To provide guidance on the use of statistical process control (SPC) and other statistical tools for real-time production monitoring in pharmaceutical manufacturing, particularly for sterile products. : Provides data-driven proof for regulatory inspections

The core of TR 59 is moving away from the outdated "three consecutive batches" rule toward a lifecycle-based approach to validation and monitoring.

The primary goal of TR 59 is to demystify and provide practical applications for methods within the pharmaceutical and biopharmaceutical industries. By leveraging these methods, manufacturers can provide objective evidence that their products consistently meet predetermined quality characteristics. It emphasizes the use of control charts, process

SPC methods help identify "special cause" variation early, ensuring each batch aligns with the Quality Target Product Profile (QTPP) .